Treatment Indications: correction of medium to deep wrinkles and folds (nasolabial folds, marionette lines, glabellar lines, forehead creases, perioral wrinkles);, lip augmentation, shaping, and contouring;, cheek, chin, and jawline volumization;, non‑surgical rhinoplasty and nasal contour refinement;, hand rejuvenation;, neck and décolleté bio‑reinforcement;, improvement of skin elasticity, turgor, and hydration
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: mid‑dermal injection for correction of medium to deep wrinkles, folds, and gentle volumetric restoration;, hybrid gel combining 85% stabilized HA and 15% free HA, utilizing L.T.S.R. (Low Temperature Stabilization Reaction) technology for balanced elasticity, smooth injection, and even tissue integration without lump formation;, two‑stage purification process reducing residual BDDE below 2 µg/mL; providing natural‑looking correction with minimal migration (effect duration ~9–12 months)